FIELD: medicine.
SUBSTANCE: method involves additionally determining main blood plasma eosinophil cationic protein concentration using immune chemiluminescence method. The concentration being greater than 8ng/ml, intravascular leukocyte activation is to be diagnosed in patients having no allergic diseases in anamnesis distinguished by marked cell-mediated (eosinocytic) reactivity phase.
EFFECT: high accuracy in diagnosing intravascular leukocyte activation; detectable critical stages of systemic inflammatory organism response development stages.
4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING INFLAMMATORY SYSTEM RESPONSE SYNDROME CASES FROM PRINCIPLE SURVIVAL SYSTEMS DATA | 2005 |
|
RU2299019C2 |
| METHOD FOR PREDICTION OF SEPSIS FOLLOWING CARDIOSURGICAL OPERATIONS PERFORMED IN CONDITIONS OF ARTIFICIAL BLOOD CIRCULATION | 2019 |
|
RU2713930C1 |
| METHOD FOR MONITORING CRITICAL STATES DEVELOPMENT ASSOCIATED WITH INFLAMMATORY SYSTEMIC RESPONSE SYNDROME | 2005 |
|
RU2293333C2 |
| METHOD OF DIAGNOSTICS AND PREDICTION OF SEPSIS OUTCOME | 2014 |
|
RU2568870C2 |
| METHOD OF PREVENTING ACUTE LUNG INJURY IN THE SURGICAL TREATMENT OF NON-SMALL CELL LUNG CANCER COMPLICATED BY AN INFLAMMATORY PROCESS | 2022 |
|
RU2801089C1 |
| METHOD FOR DETERMINING HEMOSTASIS CRITERIA FOR PREDICTING UNFAVORABLE SEPSIS OUTCOME IN ACUTE MYELOBLASTOSIS CASES | 2006 |
|
RU2320996C1 |
| METHOD OF PREDICTING SEVERE SEPSIS IN PATIENTS WITH ACUTE POISONING BY SUBSTANCES WITH NARCOTIC ACTION | 2013 |
|
RU2549455C2 |
| METHOD FOR DETECTING HYPERCOAGULATION AND INTRAVASCULAR COAGULATION ACTIVATION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA IN MANIFESTATION | 2012 |
|
RU2497127C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF LIFE-THREATENING AURICULAR ARRYTHMIA IN PATIENTS WITH HYPERTENSION DISEASE | 2016 |
|
RU2634246C1 |
| METHOD FOR LABORATORY VERIFICATION OF INFECTIONS IN PATIENTS WITH ACUTE MANIFESTED MYELOID LEUKEMIA | 2011 |
|
RU2462711C1 |
